Matthew J Sweet Selected Research

Matthew J Sweet Research Topics

Disease

20	Infections 12/2021 - 03/2009
18	Inflammation (Inflammations) 03/2022 - 09/2006
7	Neoplasms (Cancer) 01/2021 - 01/2012
6	Fibrosis (Cirrhosis) 12/2019 - 04/2012
5	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2012
4	Bacterial Infections (Bacterial Infection) 01/2018 - 09/2011
3	Liver Diseases (Liver Disease) 01/2022 - 01/2015
3	Urinary Tract Infections (Urinary Tract Infection) 11/2020 - 02/2016
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2019 - 01/2018
3	Colitis 01/2017 - 12/2015
3	Atherosclerosis 11/2015 - 07/2011
2	Poisoning 01/2021 - 01/2019
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2018 - 04/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017 - 01/2009
2	Reperfusion Injury 01/2017 - 01/2009
2	Arthritis (Polyarthritis) 02/2016 - 01/2009
2	Melanoma (Melanoma, Malignant) 08/2015 - 08/2012
2	Salmonella Infections (Salmonellosis) 07/2014 - 05/2012
2	Asthma (Bronchial Asthma) 08/2010 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2009 - 01/2009
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Bites and Stings (Sting) 10/2021
1	Hyperplasia 10/2021
1	Pyelonephritis 11/2020
1	Wilms Tumor (Wilm's Tumor) 12/2019
1	Cicatrix (Scar) 10/2019
1	Fatty Liver 01/2018
1	Sepsis (Septicemia) 10/2017
1	Meningitis 10/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Rupture 04/2016
1	Chronic Disease (Chronic Diseases) 02/2016
1	Experimental Arthritis 02/2016
1	Disease Progression 02/2016

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2007
9	Histone Deacetylases (Histone Deacetylase)IBA 03/2022 - 07/2011
8	Histone Deacetylase InhibitorsIBA 10/2019 - 12/2007
7	Messenger RNA (mRNA)IBA 01/2015 - 12/2007
5	InflammasomesIBA 04/2016 - 08/2012
4	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2016
4	ZincIBA 01/2021 - 01/2016
4	CytokinesIBA 10/2019 - 10/2013
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 08/2012
3	EnzymesIBA 01/2021 - 01/2012
3	CollagenIBA 10/2019 - 01/2011
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 01/2011
3	LipopolysaccharidesIBA 02/2016 - 01/2011
2	Peptides (Polypeptides)IBA 12/2021 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 11/2015
2	MetalsIBA 01/2021 - 07/2013
2	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2018
2	Extracellular Matrix ProteinsIBA 01/2018 - 10/2009
2	Pattern Recognition ReceptorsIBA 01/2018 - 04/2016
2	Virulence Factors (Pathogenicity Factors)IBA 10/2017 - 02/2013
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017 - 12/2015
2	Dextrans (Dextran)FDA Link 01/2017 - 12/2015
2	Apolipoproteins E (ApoE)IBA 01/2016 - 03/2014
2	ApolipoproteinsIBA 01/2016 - 03/2014
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2013 - 04/2008
2	Macrophage Colony-Stimulating FactorIBA 02/2009 - 09/2006
1	Growth Hormone (Somatotropin)IBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022
1	Tachypleus tridentatus tachyplesin peptideIBA 12/2021
1	Cell-Penetrating PeptidesIBA 12/2021
1	MethyltransferasesIBA 10/2021
1	AlloysIBA 01/2021
1	SaltsIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 11/2020
1	GlycosaminoglycansIBA 12/2019
1	Hyaluronan SynthasesIBA 12/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2019
1	Hyaluronic Acid (Hyaluronan)IBA 12/2019
1	HymecromoneIBA 12/2019
1	Toll-Like Receptor 4IBA 12/2019
1	Thioacetamide (Thioacetamid)IBA 10/2019
1	Proto-Oncogene Proteins c-etsIBA 01/2018
1	ChemokinesIBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Versicans (Versican)IBA 01/2018
1	Follistatin-Related ProteinsIBA 01/2018
1	Immunologic Factors (Immunomodulators)IBA 10/2017
1	Capsules (Microcapsules)IBA 10/2017
1	polysaccharide-KIBA 10/2017
1	Polysaccharides (Glycans)IBA 10/2017
1	BML-281IBA 01/2017
1	Toll-Like Receptor 3IBA 01/2017
1	CytochromesIBA 10/2016
1	Free RadicalsIBA 10/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016
1	Oxidoreductases (Dehydrogenase)IBA 10/2016
1	aluminum sulfate (alum)IBA 04/2016
1	leucyl-leucine-methyl esterIBA 04/2016
1	Vorinostat FDA Link 02/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Cyclic PeptidesIBA 01/2016
1	trypsin inhibitor MCoTI-IIIBA 01/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2016

Therapy/Procedure

3	Therapeutics 12/2019 - 11/2015